cdmo.directory
← Compare landing

Maravai LifeSciences vs TriLink BioTechnologies

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/maravai/trilinkbiotech

CategoryMaravai LifeSciencesTriLink BioTechnologies
Listed sitecdmocdmo
SummaryLeading provider of nucleic acid products, custom enzymes, and bioprocess analytics supporting vaccine, therapeutic, and diagnostic development from discovery through commercialization, with mRNA CDMO services including proprietary CleanCap® capping technology.TriLink manufactures mRNA, oligonucleotides, and modified nucleotides with proprietary CleanCap® capping technology achieving >95% Cap1 efficiency, supported by in-house analytical method development and a 118,000 sq ft GMP-capable facility.
Services
  • mRNA Manufacturing
  • Oligonucleotide Manufacturing
  • Vaccine Manufacturing
  • Recombinant Protein Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Quality Control Testing
  • Process Development
  • Cell-Line Development
  • CMC Analytical Development
  • Stability Testing & Storage
  • Technology Transfer
  • mRNA Manufacturing
  • Oligonucleotide Manufacturing
  • CMC Analytical Development
  • Process Development
  • Quality Control Testing
  • API Synthesis & Manufacturing
Modalities
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Oligonucleotide
  • mRNA
  • Gene Therapy
  • Vaccine
  • mRNA
  • Oligonucleotide
Indications
  • Oncology
  • Neurology
  • Cardiovascular
  • Infectious Disease
  • Rare Disease
Data not yet provided.
LocationsData not yet provided.
  • Headquarters
Certifications
  • ISO · Identifier: ISO-9001:2015
  • ISO · Identifier: ISO-9001:2015
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.